- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07445165
Investigation of Motor Imagery Ability in Relation to Body Awareness and Joint Position Sense in Healthy Subjects (MI-BA-JPS)
Motor imagery (MI) is a dynamic mental state in which representations of a specific motor movement are rehearsed in working memory without any movement manifestation. It is practiced in physiotherapy clinics to improve motor performance and learn motor tasks. Since the efficiency of the practice depends on the quality of imagery, it is necessary to assess imagery ability before performing an imagery experiment or participating in an imagery training program.
Body awareness is used as a general concept for body management, body experience and body use. It contains information about the parts of the body and includes position perception, movement sense and the conditions required for movements, mental elements (cognitive thought processes). Joint position sense, which has an important role in postural control, is defined as being aware of the position and movement of the joint in space by the central nervous system. Although it has been shown that there are factors related to the central nervous system such as cognitive level that affect motor imagery ability, there are no studies showing the relationship between body awareness and joint position sense, in which central nervous and sensory systems work in integration, and motor imagery ability. In this study, motor imagery ability will be evaluated in healthy subjects and its relationship with body awareness and joint position sense will be investigated.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Zeytinburnu
-
Istanbul, Zeytinburnu, Turkey (Türkiye), 34015
- Arel University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Volunteering to participate in the study
- Aged between 20-40 years old
- Having a Standardized Mini-Mental State Examination score higher than 24 points.
Exclusion Criteria:
- Having any musculoskeletal system disease
- Having any chronic disease
- Having a history of physical trauma
- Cognitive impairment
- Having a neurological problem
- Using analgecis for a long time
- Having a complaint of pain during the evaluation
- Using sedatives and/or antidepressants
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Only assessment research
|
This is a scale.
This is a scale.
This outcomes is mobile application.
We used by assesment brain lateralisation skills.
This is a scale.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor Imagery Ability Assessed by the Movement Imagery Questionnaire-3 (MIQ-3)
Time Frame: At baseline (single assessment at study enrollment)
|
Explicit motor imagery ability will be assessed using the Movement Imagery Questionnaire-3 (MIQ-3).
The MIQ-3 evaluates individuals' ability to imagine movements from visual and kinesthetic perspectives using self-reported ratings.
The total MIQ-3 score will be used for analysis.
|
At baseline (single assessment at study enrollment)
|
|
Body Awareness Assessed by the Body Awareness Questionnaire (BAQ)
Time Frame: At baseline (single assessment at study enrollment)
|
Body awareness will be assessed using the Body Awareness Questionnaire (BAQ), a self-report instrument designed to evaluate individuals' awareness of bodily processes, postural changes, and internal bodily sensations.
The total BAQ score will be calculated and used for statistical analysis.
|
At baseline (single assessment at study enrollment)
|
|
Motor Imagery Ability Assessed by the Vividness of Movement Imagery Questionnaire-2 (VMIQ-2)
Time Frame: At baseline (single assessment at study enrollment)
|
Explicit motor imagery vividness will be assessed using the Vividness of Movement Imagery Questionnaire-2 (VMIQ-2).
The VMIQ-2 measures the vividness of visual and kinesthetic motor imagery through self-reported responses.
Subscale and total scores will be used for statistical analysis.
|
At baseline (single assessment at study enrollment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implicit Motor Imagery Assessed by the Hand Laterality Judgment Task (Recognise™)
Time Frame: At baseline (single assessment at study enrollment)
|
Implicit motor imagery ability will be assessed using the Hand Laterality Judgment Task implemented via the Recognise™ mobile application.
Participants will be asked to identify whether displayed hand images represent the left or right hand.
Response time and accuracy will be recorded and used for analysis.
|
At baseline (single assessment at study enrollment)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ArelETK-2023/08
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurologic Deficits
-
Maharishi Markendeswar University (Deemed to be...Not yet recruitingWorking Memory Deficits
-
Ohio State UniversityVelimir MatkovicWithdrawnNeuromuscular Deficits | Musculoskeletal DeficitsUnited States
-
Bradley HospitalThrasher Research Fund; Rhode Island FoundationCompletedADHD With Working Memory DeficitsUnited States
-
Methodist Health SystemCompleted
-
Universidade do PortoRecruitingCarotid EndarterectomyPortugal
-
Ain Shams UniversityUnknownStroke With Hemiparesis | Perinatal Stroke | Focal Neurologic DeficitsEgypt
-
University Hospital, Strasbourg, FranceSuspended
-
Rush University Medical CenterRecruiting
-
Taipei Medical University Shuang Ho HospitalTaipei Medical UniversityCompletedMemory Deficits Schizophrenia Neurostimulator; ComplicationsTaiwan
-
The London Spine CentreCompletedThoracolumbar Burst Fractures Without Neurologic DeficitCanada
Clinical Trials on Movement Imagery Questionnaire-3 (MIQ-3)
-
Centre Hospitalier Universitaire de NīmesCompletedHealthy | Complex Regional Pain Syndromes | Musculoskeletal Pain DisorderFrance
-
Chinese University of Hong KongCompletedBenign Prostatic Hyperplasia (BPH)Hong Kong
-
University Hospitals Cleveland Medical CenterCompletedPatient Satisfaction | Hysterectomy | Minimally Invasive Surgery | Goal AchievementUnited States
-
Prof. Dr. med. Serge MarbacherKantonsspital AarauCompletedAneurysm CerebralSwitzerland
-
Medical University of South CarolinaNational Institute of Mental Health (NIMH)Not yet recruitingTrauma Exposure | Posttraumatic Stress Disorder (PTSD)United States
-
DreemCompletedSleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Insomnia, SecondaryUnited States
-
Haukeland University HospitalOslo University Hospital; Norwegian School of Sport SciencesCompletedDuchenne Muscular DystrophyNorway
-
Children's Hospitals and Clinics of MinnesotaCompletedFirearm Injury | Firearm Safety | Firearm OwnershipUnited States
-
Royal Marsden NHS Foundation TrustUnknownBreast CancerUnited Kingdom
-
Nantes University HospitalNot yet recruitingBipolar Disorder | Behavioral Variant of Frontotemporal Disorder (bvFTD) | Phenocopy Frontotemporal Dementia (phFTD) | Frontal Variant of Alzheimer Disease